Did AbbVie Collect or Use Your Genetic Data Without Your Permission? You Could Be Owed Thousands
If you provided personal or genetic health information to AbbVie—for a clinical study, trial, wellness program, or any other purpose—you may be eligible to join a class action lawsuit under the Illinois Genetic Information Privacy Act (GIPA).
Our legal team is actively investigating claims that AbbVie may have collected, used, or shared your sensitive genetic or health data without obtaining proper, informed consent as required by law.
What Is GIPA?
The Illinois Genetic Information Privacy Act (GIPA) protects your genetic and health information by requiring companies like AbbVie to obtain your explicit, informed written consent before collecting or using such data. It also mandates strict confidentiality to safeguard your privacy.
You May Qualify If:
You are an Illinois resident
- You provided AbbVie with personal or genetic health information
- You were not properly informed or did not give written consent for the collection or use of your data
- This occurred within the last 3 years
Why This Matters
Violating GIPA can result in serious consequences for companies, including penalties ranging from $2,500 to $15,000 per affected individual. Even unintentional misuse or lack of consent may make you eligible for damages.
You Could Be Entitled to Compensation
You don’t need to prove that you were harmed. Simply having your genetic data collected, used, or shared without your informed consent could qualify you for financial compensation.
Join the Investigation Today
If you believe AbbVie mishandled your genetic or health data, don’t wait to protect your rights. Contact us for a free case evaluation—there are no upfront fees, and we only get paid if you win.
Contact Us Today to See If You Qualify
Contact our legal team for a fast, no-obligation review.
Call us now at 888-747-4529, Text 440-381-0338, or Email NewIntakes@sirillp.com to get a free case evaluation and find out if you qualify for compensation.